rs386833748
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001378615.1(CC2D2A):c.2773C>T(p.Arg925*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000434 in 1,612,388 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001378615.1 stop_gained
Scores
Clinical Significance
Conservation
Publications
- ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Joubert syndrome 9Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- retinitis pigmentosa 93Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- COACH syndrome 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Joubert syndrome with oculorenal defectInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Meckel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CC2D2A | NM_001378615.1 | c.2773C>T | p.Arg925* | stop_gained | Exon 21 of 37 | ENST00000424120.6 | NP_001365544.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CC2D2A | ENST00000424120.6 | c.2773C>T | p.Arg925* | stop_gained | Exon 21 of 37 | 5 | NM_001378615.1 | ENSP00000403465.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151954Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000122 AC: 3AN: 246056 AF XY: 0.0000150 show subpopulations
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1460434Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726468 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151954Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74206 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense-mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 33486889, 25525159, 31964843, 19777577) -
Meckel-Gruber syndrome;C0431399:Joubert syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg925*) in the CC2D2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CC2D2A are known to be pathogenic (PMID: 19777577). This variant is present in population databases (rs386833748, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with Meckel syndrome (PMID: 19777577). ClinVar contains an entry for this variant (Variation ID: 56300). For these reasons, this variant has been classified as Pathogenic. -
Meckel syndrome, type 6 Pathogenic:1
- -
CC2D2A-related disorder Pathogenic:1
The CC2D2A c.2773C>T (p.Arg925Ter) variant is a stop-gained variant that is predicted to result in a premature termination of the protein. The p.Arg925Ter variant has been reported in a compound heterozygous state with a splice site variant in a fetus diagnosed at 16 weeks gestation with cystic kidneys characteristic of Meckel syndrome, bile duct proliferation of the liver, occipital meningocele of the central nervous system, and polydactyly (Mougou-Zerelli et al. 2009). Akizu et al. (2014) found this variant in a homozygous state in an individual from a consanguineous union described as having classic Joubert syndrome. An immunoblot assay in fibroblasts from this homozygous individual revealed severely reduced protein levels. Control data are unavailable for this variant, which is not found in the 1000 Genomes Project, the Exome Sequencing Project, the Exome Aggregation Consortium, or the Genome Aggregation Database. Based on the evidence and due to the potential impact of stop-gained variants, the p.Arg925Ter variant is classified as likely pathogenic CC2D2A-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at